DOW JONES22,345.60+708.82 3.28%
S&P 5002,629.33+87.86 3.46%
NASDAQ7,774.15+271.77 3.62%

Barclays Initiates Coverage On Agios Pharmaceuticals with Equal-Weight Rating, Announces $50 Price Target

Barclays analyst Peter Lawson initiates coverage on Agios Pharmaceuticals (NASDAQ:AGIO) with a Equal-Weight rating and a $50 price target.

Benzinga · 03/04/2020 10:34

Barclays analyst Peter Lawson initiates coverage on Agios Pharmaceuticals (NASDAQ:AGIO) with a Equal-Weight rating and a $50 price target.